With basic researchers on AD, AD clinicians, national AD networks, drug development companies, local healthcare givers, and municipal institutions, we aim to establish the Norwegian Alzheimer's disease network (NO-AD, Fig. 2). The aim of this network..
Relevance: 11.303854